Medical body demands ban on 33 drugs in India Hyderabad, May 20, 2012.

The All India Drugs Control Officers Confederation (AIDCOC) has demanded that the Union health ministry suspend the approval granted to 33 drugs for sale in India with immediate effect, as the approval was given without conducting the required clinical trials.

The federation claimed that the Central Drugs Standard Control Organisation (CDSCO) had granted permission for the marketing of 33 drugs without carrying out clinical trials in India. Recently, the Parliamentary Standing Committee on health had found that between 2008 and 2010, 33 new foreign drugs were approved for marketing without phase III clinical trials on patients.

R. Uday Bhaskar, secretary-general of AIDCOC, criticised the CDSCO for its “nexus with pharmaceutical companies who are, in turn, in collusion with medical experts to obtain clearance for the drugs”. He said: “We want a thorough investigation in the case in the interest of the public.” The government should cancel the manufacturing or sale license of the drug manufacturers,” he said. Read more